Pricing Log in Create free account
Sunday 18 October 2026 Export AGMB’s income statement to Excel — free account

AgomAb Therapeutics NV

AGMB

Insiders bought in the last twelve months.

8.28 0.05 −0.60%
Market cap
$410.3M
P/E
—
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a
Overview Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

AgomAb Therapeutics NV (AGMB) P/E ratio

Alert me on P/E ratio

P/E ratio, daily

No history to chart for AGMB yet.

Annual newest first

Period P/E ratio Change

P/E ratio against peers

Company P/E ratio
AGMB AgomAb Therapeutics NV —
Market median 18.1×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on AGMB